Condition: Adenocarcinoma · Sponsor: Centre Hospitalier Universitaire de Saint Etienne
This study is about pancreatic cancer. If the diagnostic cancer is done at an early stage (\<2cm), the chances of recovery are very good. But the main problem is there is not any detections means for this cancer. Sadly, when there is a cancer diagnostic , it's already too late in the majority of cases, because the cancer is in an advanced case. Today, there is no any effective means of detection... Blood markers can be a simple means of early detection
This description comes directly from the study's public registry record.
Nicolas WILLIET, MD · (0)477829029 · nicolas.williet@chu-st-etienne.fr
Jean-Marc PHELIP, MD-PhD · ( 0)477828320 · j.marc.phelip@chu-st-etienne.fr
Always discuss trial participation with your own doctor first.
| CHU Saint-Etienne | Saint-Etienne, France | Recruiting |
| Institut Cancérologique Lucien Newirth (ICLN) | Saint-Priest-en-Jarez, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04374175